Liquid Biopsy for Early Detection of Recurrence in Gastric Cancer
Author Information
Author(s): P. Ding, J. Wu, H. Wu, T. Li, X. Niu, P. Yang, H. Guo, Y. Tian, J. He, J. Yang, R. Gu, L. Zhang, N. Meng, X. Li, Z. Guo, L. Meng, Q. Zhao
Primary Institution: The Fourth Hospital of Hebei Medical University
Hypothesis
Can a transcriptomics-based liquid biopsy improve early detection of recurrence in locally advanced gastric cancer?
Conclusion
The study developed a non-invasive liquid biopsy method using a 4-mRNA panel that significantly improves early detection of recurrence in locally advanced gastric cancer.
Supporting Evidence
- Four mRNA biomarkers linked to recurrence were identified.
- The RSA model showed an AUC of 0.919 in validation cohorts.
- Silencing the mRNA panel genes impaired cancer cell migration and proliferation.
- The model improved detection rates in high-risk patients.
- Patients with high-risk scores had significantly worse overall survival.
Takeaway
Doctors can use a simple blood test to find out if stomach cancer is coming back, which helps them treat patients better.
Methodology
The study used mRNA sequencing and qRT-PCR to identify and validate a panel of four mRNA biomarkers in tissue and blood samples from gastric cancer patients.
Potential Biases
Potential bias due to the retrospective nature of some analyses and the specific patient cohorts used.
Limitations
The study did not explore specific clinical implications or decision-making algorithms based on risk stratification.
Participant Demographics
Patients diagnosed with locally advanced gastric cancer, with a focus on those undergoing surgical resection.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI: 0.825-0.902
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website